Cerner Capital

Cerner Capital Management is a highly disciplined investment firm dedicated to growing equity returns for corporations, government entities, foundations, trusts and private investors. Our unique, risk-discerning investment approach produces consistent returns at lower risk. Cerner Capital's principals are established advisors with significant experience in the areas of investment management and tax advisory solutions. Investors choose us to grow and protect their portfolios in highly fluctuating markets.

Raymond Payne

Managing Partner

8 past transactions

Carevive Systems

Series C in 2021
Carevive Systems provides personalized and dynamic cancer care plans for patients that improve clinical outcomes and enable oncology practices to operate in emerging value-based models. Its care plans continuously update to provide ongoing guidance to patients based on their experiences throughout the journey. Located in North Miami, Florida.

Xealth

Venture Round in 2020
Xealth scales digital health programs, enabling clinicians to integrate, prescribe and monitor digital health tools for patients to drive engagement and utilization. Through the secure Xealth platform, clinicians can find and order the right digital health tools and programs for patients directly from the EHR workflow, send these digital health orders to the patient’s email or patient portal, and then monitor activity.

Carevive Systems

Series C in 2020
Carevive Systems provides personalized and dynamic cancer care plans for patients that improve clinical outcomes and enable oncology practices to operate in emerging value-based models. Its care plans continuously update to provide ongoing guidance to patients based on their experiences throughout the journey. Located in North Miami, Florida.

Voalte

Series D in 2015
Voalte is a healthcare technology company that develops smartphone communication alternatives to help improve care coordination. They offer a comprehensive mobile communication strategy, that enables care teams inside and outside the hospital to access and exchange information securely. The company customers benefit from a solid smartphone infrastructure that supports their existing systems and expands to accommodate future technologies. Voalte is the only company to provide a fully integrated and dependable communication alternative that supports care teams and future mobile healthcare technologies.

Cureatr

Series B in 2015
Cureatr develops a cloud-based medication management software to optimize patient care. It offers healthcare management services that focus on post-discharge medication reconciliation and other medical services triggered by real-time events.

Sotera Wireless

Venture Round in 2014
Sotera Wireless, Inc. is a medical device company dedicated to the development, marketing and sale of a new generation of comprehensive vital signs monitoring. Sotera’s mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient’s freedom of movement.

Claritas Genomics

Series A in 2013
Claritas Genomics is a new venture, formed through a partnership between Boston Children's Hospital and Life Technologies Corp. Claritas develops next-generation, genetic and genomics-based diagnostic testing solutions. The venture combines advanced instrumentation, software and bioinformatics capabilities with sophisticated clinical interpretation by specialist physicians and medical genomics experts at Boston Children’s Hospital, a Harvard teaching hospital and the top-ranked pediatric hospital in the US.

Sotera Wireless

Series D in 2013
Sotera Wireless, Inc. is a medical device company dedicated to the development, marketing and sale of a new generation of comprehensive vital signs monitoring. Sotera’s mission is to improve patient safety by empowering clinicians to detect early signs of deterioration in virtually any care setting and enable early intervention and rapid response, all without limiting the patient’s freedom of movement.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.